Article
Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout.
Rheumatology (Oxford, England) - 1 Oct 2024
Zhao Sizheng Steven, Cuthbertson Daniel J, Alam Uazman
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
